BRAF and differentiated thyroid carcinoma: However, lncRNAs induced by other oncogenes have also been reported, as the oncogenic RAS-induced lncRNA 1 (Orilnc1)—identified in breast and melanoma cells as being induced by mutated BRAF [172]—and the cytosolic oncogenic antisense to MET transcript (COMETT), over-expressed in BRAF-mutated and RET-rearranged papillary thyroid carcinomas [173].